Institutions / STEMPOINT CAPITAL LP / Holdings
Back to STEMPOINT CAPITAL LP

Stempoint Capital LP

All holdings · as of Dec 31, 2025

75 positions

CompanyClassValue ↓Shares% of portfolio
ABIVAX SA—$52.83M391,7839.1%
Scholar Rock Holding Corp—$39.07M886,8936.7%
CENTESSA PHARMACEUTICALS PLC—$28.86M1,154,1145.0%
Syndax Pharmaceuticals Inc—$28.14M1,339,3794.8%
Structure Therapeutics Inc.GPCRADR$24.42M351,0734.2%
Arcellx, Inc.—$21.70M332,8603.7%
Roivant Sciences Ltd.—$20.98M966,6983.6%
Terns Pharmaceuticals, Inc.—$17.34M429,1983.0%
Twist Bioscience Corp—$16.44M518,3552.8%
Immunovant, Inc.IMVTCommon Stock$16.39M644,9592.8%
Dyne Therapeutics, Inc.—$16.34M835,2002.8%
Xenon Pharmaceuticals Inc.—$15.62M348,6052.7%
Surrozen, Inc./DESRZNCommon Stock$12.67M619,7662.2%
Celcuity Inc.CELCCommon Stock$11.80M118,3332.0%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$10.53M290,0491.8%
MADRIGAL PHARMACEUTICALS, INC.—$10.33M17,7361.8%
Adaptive Biotechnologies Corp—$9.85M606,8251.7%
PALISADE BIO, INC.—$9.85M4,192,3751.7%
Cytokinetics Inc—$9.34M146,9781.6%
Edgewise Therapeutics, Inc.—$8.96M360,8761.5%
BRIGHT MINDS BIOSCIENCES INC.—$7.60M97,3401.3%
NEKTAR THERAPEUTICS—$7.54M178,2741.3%
JOHNSON & JOHNSON—$7.24M35,0001.2%
Denali Therapeutics Inc.—$6.92M419,0581.2%
Amylyx Pharmaceuticals, Inc.—$6.83M565,1401.2%
ClearPoint Neuro, Inc.—$6.59M481,8581.1%
Arcutis Biotherapeutics, Inc.—$6.53M224,7401.1%
EyePoint, Inc.—$6.46M353,8491.1%
IMMATICS N.V—$6.41M610,3081.1%
Ocular Therapeutix, Inc—$6.35M522,6931.1%
RHYTHM PHARMACEUTICALS, INC.—$6.31M58,9151.1%
Praxis Precision Medicines, Inc.—$6.21M21,0671.1%
Apogee Therapeutics, Inc.—$6.08M80,5741.0%
INCYTE CORP—$6.07M61,4351.0%
IDEAYA BIOSCIENCES, INC.—$5.59M161,6591.0%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$5.33M156,7280.9%
Maze Therapeutics, Inc.—$5.22M125,8770.9%
PROTAGONIST THERAPEUTICS INC—$5.19M59,4300.9%
ELI LILLY & Co—$5.11M4,7590.9%
Trevi Therapeutics, Inc.—$5.00M399,5570.9%
Revolution Medicines, Inc.—$4.94M62,0320.8%
Viridian Therapeutics, Inc.—$4.80M154,3200.8%
Arbutus Biopharma CorpABUSCommon Stock$4.75M986,7510.8%
MoonLake ImmunotherapeuticsMLTXCommon Stock$4.59M348,4010.8%
CytomX Therapeutics, Inc.—$4.41M1,036,3110.8%
X4 Pharmaceuticals, Inc—$3.59M898,4650.6%
Whitehawk Therapeutics, Inc.WHWKCommon Stock$3.53M1,458,8070.6%
Dianthus Therapeutics, Inc.—$3.27M79,2840.6%
ASCENDIS PHARMA A/S—$3.16M14,8420.5%
REPLIGEN CORP—$2.57M15,7070.4%
← PrevPage 1 of 2Next →